0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Implantable Contraceptive Drug Eluting Devices Market Research Report 2026
Published Date: 2026-02-03
|
Report Code: QYRE-Auto-15T18630
Home | Market Reports | Health| Reproductive Health
Global Implantable Contraceptive Drug Eluting Devices Market Research Report 2024
BUY CHAPTERS

Global Implantable Contraceptive Drug Eluting Devices Market Research Report 2026

Code: QYRE-Auto-15T18630
Report
2026-02-03
Pages:128
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Implantable Contraceptive Drug Eluting Devices Market Size

The global Implantable Contraceptive Drug Eluting Devices market was valued at US$ 4471 million in 2025 and is anticipated to reach US$ 5822 million by 2032, at a CAGR of 3.9% from 2026 to 2032.

Implantable Contraceptive Drug Eluting Devices Market

Implantable Contraceptive Drug Eluting Devices Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Implantable Contraceptive Drug Eluting Devices competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Implantable Contraceptive Drug-Eluting Devices are medical devices designed to release contraceptive drugs over a prolonged period to prevent pregnancy. These devices are implanted in the body or placed in specific areas, gradually releasing hormones that inhibit ovulation or prevent sperm from fertilizing an egg. Common examples include intrauterine devices (IUDs) and subdermal implants, which are effective, reversible, and provide long-term contraception without requiring daily action.
The North American market for Implantable Contraceptive Drug Eluting Devices is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Implantable Contraceptive Drug Eluting Devices is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Implantable Contraceptive Drug Eluting Devices include Bayer, AbbVie, CooperSurgical, Egemen International, ERENLER MEDIKAL, Gyneas, Laboratoire CCD, Medical Engineering Corporation, Melbea, Meril Life Sciences, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Implantable Contraceptive Drug Eluting Devices market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Implantable Contraceptive Drug Eluting Devices. The Implantable Contraceptive Drug Eluting Devices market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Implantable Contraceptive Drug Eluting Devices market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Implantable Contraceptive Drug Eluting Devices manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Implantable Contraceptive Drug Eluting Devices Market Report

Report Metric Details
Report Name Implantable Contraceptive Drug Eluting Devices Market
Accounted market size in 2025 US$ 4471 million
Forecasted market size in 2032 US$ 5822 million
CAGR 3.9%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Non-biodegradable
  • Biodegradable
by Application
  • Subcutaneously
  • Uterus
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bayer, AbbVie, CooperSurgical, Egemen International, ERENLER MEDIKAL, Gyneas, Laboratoire CCD, Medical Engineering Corporation, Melbea, Meril Life Sciences, Mona Lisa, Pregna International, Prosan International, Rongbo Medical, SMB Corporation of India, Pregna
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Implantable Contraceptive Drug Eluting Devices manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Implantable Contraceptive Drug Eluting Devices sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Implantable Contraceptive Drug Eluting Devices Market growing?

Ans: The Implantable Contraceptive Drug Eluting Devices Market witnessing a CAGR of 3.9% during the forecast period 2026-2032.

What is the Implantable Contraceptive Drug Eluting Devices Market size in 2032?

Ans: The Implantable Contraceptive Drug Eluting Devices Market size in 2032 will be US$ 5822 million.

Who are the main players in the Implantable Contraceptive Drug Eluting Devices Market report?

Ans: The main players in the Implantable Contraceptive Drug Eluting Devices Market are Bayer, AbbVie, CooperSurgical, Egemen International, ERENLER MEDIKAL, Gyneas, Laboratoire CCD, Medical Engineering Corporation, Melbea, Meril Life Sciences, Mona Lisa, Pregna International, Prosan International, Rongbo Medical, SMB Corporation of India, Pregna

What are the Application segmentation covered in the Implantable Contraceptive Drug Eluting Devices Market report?

Ans: The Applications covered in the Implantable Contraceptive Drug Eluting Devices Market report are Subcutaneously, Uterus

What are the Type segmentation covered in the Implantable Contraceptive Drug Eluting Devices Market report?

Ans: The Types covered in the Implantable Contraceptive Drug Eluting Devices Market report are Non-biodegradable, Biodegradable

1 Implantable Contraceptive Drug Eluting Devices Market Overview
1.1 Product Definition
1.2 Implantable Contraceptive Drug Eluting Devices by Type
1.2.1 Global Implantable Contraceptive Drug Eluting Devices Market Value by Type: 2025 vs 2032
1.2.2 Non-biodegradable
1.2.3 Biodegradable
1.3 Implantable Contraceptive Drug Eluting Devices by Application
1.3.1 Global Implantable Contraceptive Drug Eluting Devices Market Value by Application: 2025 vs 2032
1.3.2 Subcutaneously
1.3.3 Uterus
1.4 Global Implantable Contraceptive Drug Eluting Devices Market Size Estimates and Forecasts
1.4.1 Global Implantable Contraceptive Drug Eluting Devices Revenue 2021–2032
1.4.2 Global Implantable Contraceptive Drug Eluting Devices Sales 2021–2032
1.4.3 Global Implantable Contraceptive Drug Eluting Devices Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Implantable Contraceptive Drug Eluting Devices Market Competition by Manufacturers
2.1 Global Implantable Contraceptive Drug Eluting Devices Sales Market Share by Manufacturers (2021–2026)
2.2 Global Implantable Contraceptive Drug Eluting Devices Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Implantable Contraceptive Drug Eluting Devices Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Implantable Contraceptive Drug Eluting Devices, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Implantable Contraceptive Drug Eluting Devices, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Implantable Contraceptive Drug Eluting Devices, Product Types and Applications
2.7 Global Key Manufacturers of Implantable Contraceptive Drug Eluting Devices, Date of Entry into the Industry
2.8 Global Implantable Contraceptive Drug Eluting Devices Market Competitive Situation and Trends
2.8.1 Global Implantable Contraceptive Drug Eluting Devices Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Implantable Contraceptive Drug Eluting Devices Players Market Share by Revenue
2.8.3 Global Implantable Contraceptive Drug Eluting Devices Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Implantable Contraceptive Drug Eluting Devices Market Scenario by Region
3.1 Global Implantable Contraceptive Drug Eluting Devices Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Implantable Contraceptive Drug Eluting Devices Sales by Region: 2021–2032
3.2.1 Global Implantable Contraceptive Drug Eluting Devices Sales by Region: 2021–2026
3.2.2 Global Implantable Contraceptive Drug Eluting Devices Sales by Region: 2027–2032
3.3 Global Implantable Contraceptive Drug Eluting Devices Revenue by Region: 2021–2032
3.3.1 Global Implantable Contraceptive Drug Eluting Devices Revenue by Region: 2021–2026
3.3.2 Global Implantable Contraceptive Drug Eluting Devices Revenue by Region: 2027–2032
3.4 North America Implantable Contraceptive Drug Eluting Devices Market Facts & Figures by Country
3.4.1 North America Implantable Contraceptive Drug Eluting Devices Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Implantable Contraceptive Drug Eluting Devices Sales by Country (2021–2032)
3.4.3 North America Implantable Contraceptive Drug Eluting Devices Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Implantable Contraceptive Drug Eluting Devices Market Facts & Figures by Country
3.5.1 Europe Implantable Contraceptive Drug Eluting Devices Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Implantable Contraceptive Drug Eluting Devices Sales by Country (2021–2032)
3.5.3 Europe Implantable Contraceptive Drug Eluting Devices Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Implantable Contraceptive Drug Eluting Devices Market Facts & Figures by Region
3.6.1 Asia Pacific Implantable Contraceptive Drug Eluting Devices Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Implantable Contraceptive Drug Eluting Devices Sales by Region (2021–2032)
3.6.3 Asia Pacific Implantable Contraceptive Drug Eluting Devices Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Implantable Contraceptive Drug Eluting Devices Market Facts & Figures by Country
3.7.1 Latin America Implantable Contraceptive Drug Eluting Devices Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Implantable Contraceptive Drug Eluting Devices Sales by Country (2021–2032)
3.7.3 Latin America Implantable Contraceptive Drug Eluting Devices Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Implantable Contraceptive Drug Eluting Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Implantable Contraceptive Drug Eluting Devices Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Implantable Contraceptive Drug Eluting Devices Sales by Country (2021–2032)
3.8.3 Middle East and Africa Implantable Contraceptive Drug Eluting Devices Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Implantable Contraceptive Drug Eluting Devices Sales by Type (2021–2032)
4.1.1 Global Implantable Contraceptive Drug Eluting Devices Sales by Type (2021–2026)
4.1.2 Global Implantable Contraceptive Drug Eluting Devices Sales by Type (2027–2032)
4.1.3 Global Implantable Contraceptive Drug Eluting Devices Sales Market Share by Type (2021–2032)
4.2 Global Implantable Contraceptive Drug Eluting Devices Revenue by Type (2021–2032)
4.2.1 Global Implantable Contraceptive Drug Eluting Devices Revenue by Type (2021–2026)
4.2.2 Global Implantable Contraceptive Drug Eluting Devices Revenue by Type (2027–2032)
4.2.3 Global Implantable Contraceptive Drug Eluting Devices Revenue Market Share by Type (2021–2032)
4.3 Global Implantable Contraceptive Drug Eluting Devices Price by Type (2021–2032)
5 Segment by Application
5.1 Global Implantable Contraceptive Drug Eluting Devices Sales by Application (2021–2032)
5.1.1 Global Implantable Contraceptive Drug Eluting Devices Sales by Application (2021–2026)
5.1.2 Global Implantable Contraceptive Drug Eluting Devices Sales by Application (2027–2032)
5.1.3 Global Implantable Contraceptive Drug Eluting Devices Sales Market Share by Application (2021–2032)
5.2 Global Implantable Contraceptive Drug Eluting Devices Revenue by Application (2021–2032)
5.2.1 Global Implantable Contraceptive Drug Eluting Devices Revenue by Application (2021–2026)
5.2.2 Global Implantable Contraceptive Drug Eluting Devices Revenue by Application (2027–2032)
5.2.3 Global Implantable Contraceptive Drug Eluting Devices Revenue Market Share by Application (2021–2032)
5.3 Global Implantable Contraceptive Drug Eluting Devices Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Company Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Implantable Contraceptive Drug Eluting Devices Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Bayer Implantable Contraceptive Drug Eluting Devices Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 AbbVie
6.2.1 AbbVie Company Information
6.2.2 AbbVie Description and Business Overview
6.2.3 AbbVie Implantable Contraceptive Drug Eluting Devices Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 AbbVie Implantable Contraceptive Drug Eluting Devices Product Portfolio
6.2.5 AbbVie Recent Developments/Updates
6.3 CooperSurgical
6.3.1 CooperSurgical Company Information
6.3.2 CooperSurgical Description and Business Overview
6.3.3 CooperSurgical Implantable Contraceptive Drug Eluting Devices Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 CooperSurgical Implantable Contraceptive Drug Eluting Devices Product Portfolio
6.3.5 CooperSurgical Recent Developments/Updates
6.4 Egemen International
6.4.1 Egemen International Company Information
6.4.2 Egemen International Description and Business Overview
6.4.3 Egemen International Implantable Contraceptive Drug Eluting Devices Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Egemen International Implantable Contraceptive Drug Eluting Devices Product Portfolio
6.4.5 Egemen International Recent Developments/Updates
6.5 ERENLER MEDIKAL
6.5.1 ERENLER MEDIKAL Company Information
6.5.2 ERENLER MEDIKAL Description and Business Overview
6.5.3 ERENLER MEDIKAL Implantable Contraceptive Drug Eluting Devices Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 ERENLER MEDIKAL Implantable Contraceptive Drug Eluting Devices Product Portfolio
6.5.5 ERENLER MEDIKAL Recent Developments/Updates
6.6 Gyneas
6.6.1 Gyneas Company Information
6.6.2 Gyneas Description and Business Overview
6.6.3 Gyneas Implantable Contraceptive Drug Eluting Devices Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Gyneas Implantable Contraceptive Drug Eluting Devices Product Portfolio
6.6.5 Gyneas Recent Developments/Updates
6.7 Laboratoire CCD
6.7.1 Laboratoire CCD Company Information
6.7.2 Laboratoire CCD Description and Business Overview
6.7.3 Laboratoire CCD Implantable Contraceptive Drug Eluting Devices Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Laboratoire CCD Implantable Contraceptive Drug Eluting Devices Product Portfolio
6.7.5 Laboratoire CCD Recent Developments/Updates
6.8 Medical Engineering Corporation
6.8.1 Medical Engineering Corporation Company Information
6.8.2 Medical Engineering Corporation Description and Business Overview
6.8.3 Medical Engineering Corporation Implantable Contraceptive Drug Eluting Devices Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Medical Engineering Corporation Implantable Contraceptive Drug Eluting Devices Product Portfolio
6.8.5 Medical Engineering Corporation Recent Developments/Updates
6.9 Melbea
6.9.1 Melbea Company Information
6.9.2 Melbea Description and Business Overview
6.9.3 Melbea Implantable Contraceptive Drug Eluting Devices Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Melbea Implantable Contraceptive Drug Eluting Devices Product Portfolio
6.9.5 Melbea Recent Developments/Updates
6.10 Meril Life Sciences
6.10.1 Meril Life Sciences Company Information
6.10.2 Meril Life Sciences Description and Business Overview
6.10.3 Meril Life Sciences Implantable Contraceptive Drug Eluting Devices Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Meril Life Sciences Implantable Contraceptive Drug Eluting Devices Product Portfolio
6.10.5 Meril Life Sciences Recent Developments/Updates
6.11 Mona Lisa
6.11.1 Mona Lisa Company Information
6.11.2 Mona Lisa Description and Business Overview
6.11.3 Mona Lisa Implantable Contraceptive Drug Eluting Devices Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Mona Lisa Implantable Contraceptive Drug Eluting Devices Product Portfolio
6.11.5 Mona Lisa Recent Developments/Updates
6.12 Pregna International
6.12.1 Pregna International Company Information
6.12.2 Pregna International Description and Business Overview
6.12.3 Pregna International Implantable Contraceptive Drug Eluting Devices Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Pregna International Implantable Contraceptive Drug Eluting Devices Product Portfolio
6.12.5 Pregna International Recent Developments/Updates
6.13 Prosan International
6.13.1 Prosan International Company Information
6.13.2 Prosan International Description and Business Overview
6.13.3 Prosan International Implantable Contraceptive Drug Eluting Devices Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Prosan International Implantable Contraceptive Drug Eluting Devices Product Portfolio
6.13.5 Prosan International Recent Developments/Updates
6.14 Rongbo Medical
6.14.1 Rongbo Medical Company Information
6.14.2 Rongbo Medical Description and Business Overview
6.14.3 Rongbo Medical Implantable Contraceptive Drug Eluting Devices Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Rongbo Medical Implantable Contraceptive Drug Eluting Devices Product Portfolio
6.14.5 Rongbo Medical Recent Developments/Updates
6.15 SMB Corporation of India
6.15.1 SMB Corporation of India Company Information
6.15.2 SMB Corporation of India Description and Business Overview
6.15.3 SMB Corporation of India Implantable Contraceptive Drug Eluting Devices Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 SMB Corporation of India Implantable Contraceptive Drug Eluting Devices Product Portfolio
6.15.5 SMB Corporation of India Recent Developments/Updates
6.16 Pregna
6.16.1 Pregna Company Information
6.16.2 Pregna Description and Business Overview
6.16.3 Pregna Implantable Contraceptive Drug Eluting Devices Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Pregna Implantable Contraceptive Drug Eluting Devices Product Portfolio
6.16.5 Pregna Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Implantable Contraceptive Drug Eluting Devices Industry Chain Analysis
7.2 Implantable Contraceptive Drug Eluting Devices Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Implantable Contraceptive Drug Eluting Devices Production Mode & Process Analysis
7.4 Implantable Contraceptive Drug Eluting Devices Sales and Marketing
7.4.1 Implantable Contraceptive Drug Eluting Devices Sales Channels
7.4.2 Implantable Contraceptive Drug Eluting Devices Distributors
7.5 Implantable Contraceptive Drug Eluting Devices Customer Analysis
8 Implantable Contraceptive Drug Eluting Devices Market Dynamics
8.1 Implantable Contraceptive Drug Eluting Devices Industry Trends
8.2 Implantable Contraceptive Drug Eluting Devices Market Drivers
8.3 Implantable Contraceptive Drug Eluting Devices Market Challenges
8.4 Implantable Contraceptive Drug Eluting Devices Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Implantable Contraceptive Drug Eluting Devices Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Implantable Contraceptive Drug Eluting Devices Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Implantable Contraceptive Drug Eluting Devices Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Implantable Contraceptive Drug Eluting Devices Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Implantable Contraceptive Drug Eluting Devices Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Implantable Contraceptive Drug Eluting Devices Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Implantable Contraceptive Drug Eluting Devices Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Implantable Contraceptive Drug Eluting Devices Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Implantable Contraceptive Drug Eluting Devices, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Implantable Contraceptive Drug Eluting Devices, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Implantable Contraceptive Drug Eluting Devices, Product Types and Applications
 Table 12. Global Key Manufacturers of Implantable Contraceptive Drug Eluting Devices, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Implantable Contraceptive Drug Eluting Devices Companies by Tier (Tier 1, Tier 2, Tier 3), based on Implantable Contraceptive Drug Eluting Devices Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Implantable Contraceptive Drug Eluting Devices Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Implantable Contraceptive Drug Eluting Devices Sales by Region (K Units), 2021–2026
 Table 18. Global Implantable Contraceptive Drug Eluting Devices Sales Market Share by Region (2021–2026)
 Table 19. Global Implantable Contraceptive Drug Eluting Devices Sales by Region (K Units), 2027–2032
 Table 20. Global Implantable Contraceptive Drug Eluting Devices Sales Market Share by Region (2027–2032)
 Table 21. Global Implantable Contraceptive Drug Eluting Devices Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Implantable Contraceptive Drug Eluting Devices Revenue Market Share by Region (2021–2026)
 Table 23. Global Implantable Contraceptive Drug Eluting Devices Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Implantable Contraceptive Drug Eluting Devices Revenue Market Share by Region (2027–2032)
 Table 25. North America Implantable Contraceptive Drug Eluting Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Implantable Contraceptive Drug Eluting Devices Sales by Country (K Units), 2021–2026
 Table 27. North America Implantable Contraceptive Drug Eluting Devices Sales by Country (K Units), 2027–2032
 Table 28. North America Implantable Contraceptive Drug Eluting Devices Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Implantable Contraceptive Drug Eluting Devices Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Implantable Contraceptive Drug Eluting Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Implantable Contraceptive Drug Eluting Devices Sales by Country (K Units), 2021–2026
 Table 32. Europe Implantable Contraceptive Drug Eluting Devices Sales by Country (K Units), 2027–2032
 Table 33. Europe Implantable Contraceptive Drug Eluting Devices Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Implantable Contraceptive Drug Eluting Devices Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Implantable Contraceptive Drug Eluting Devices Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Implantable Contraceptive Drug Eluting Devices Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Implantable Contraceptive Drug Eluting Devices Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Implantable Contraceptive Drug Eluting Devices Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Implantable Contraceptive Drug Eluting Devices Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Implantable Contraceptive Drug Eluting Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Implantable Contraceptive Drug Eluting Devices Sales by Country (K Units), 2021–2026
 Table 42. Latin America Implantable Contraceptive Drug Eluting Devices Sales by Country (K Units), 2027–2032
 Table 43. Latin America Implantable Contraceptive Drug Eluting Devices Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Implantable Contraceptive Drug Eluting Devices Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Implantable Contraceptive Drug Eluting Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Implantable Contraceptive Drug Eluting Devices Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Implantable Contraceptive Drug Eluting Devices Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Implantable Contraceptive Drug Eluting Devices Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Implantable Contraceptive Drug Eluting Devices Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Implantable Contraceptive Drug Eluting Devices Sales (K Units) by Type (2021–2026)
 Table 51. Global Implantable Contraceptive Drug Eluting Devices Sales (K Units) by Type (2027–2032)
 Table 52. Global Implantable Contraceptive Drug Eluting Devices Sales Market Share by Type (2021–2026)
 Table 53. Global Implantable Contraceptive Drug Eluting Devices Sales Market Share by Type (2027–2032)
 Table 54. Global Implantable Contraceptive Drug Eluting Devices Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Implantable Contraceptive Drug Eluting Devices Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Implantable Contraceptive Drug Eluting Devices Revenue Market Share by Type (2021–2026)
 Table 57. Global Implantable Contraceptive Drug Eluting Devices Revenue Market Share by Type (2027–2032)
 Table 58. Global Implantable Contraceptive Drug Eluting Devices Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Implantable Contraceptive Drug Eluting Devices Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Implantable Contraceptive Drug Eluting Devices Sales (K Units) by Application (2021–2026)
 Table 61. Global Implantable Contraceptive Drug Eluting Devices Sales (K Units) by Application (2027–2032)
 Table 62. Global Implantable Contraceptive Drug Eluting Devices Sales Market Share by Application (2021–2026)
 Table 63. Global Implantable Contraceptive Drug Eluting Devices Sales Market Share by Application (2027–2032)
 Table 64. Global Implantable Contraceptive Drug Eluting Devices Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Implantable Contraceptive Drug Eluting Devices Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Implantable Contraceptive Drug Eluting Devices Revenue Market Share by Application (2021–2026)
 Table 67. Global Implantable Contraceptive Drug Eluting Devices Revenue Market Share by Application (2027–2032)
 Table 68. Global Implantable Contraceptive Drug Eluting Devices Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Implantable Contraceptive Drug Eluting Devices Price (US$/Unit) by Application (2027–2032)
 Table 70. Bayer Company Information
 Table 71. Bayer Description and Business Overview
 Table 72. Bayer Implantable Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Bayer Implantable Contraceptive Drug Eluting Devices Product
 Table 74. Bayer Recent Developments/Updates
 Table 75. AbbVie Company Information
 Table 76. AbbVie Description and Business Overview
 Table 77. AbbVie Implantable Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. AbbVie Implantable Contraceptive Drug Eluting Devices Product
 Table 79. AbbVie Recent Developments/Updates
 Table 80. CooperSurgical Company Information
 Table 81. CooperSurgical Description and Business Overview
 Table 82. CooperSurgical Implantable Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. CooperSurgical Implantable Contraceptive Drug Eluting Devices Product
 Table 84. CooperSurgical Recent Developments/Updates
 Table 85. Egemen International Company Information
 Table 86. Egemen International Description and Business Overview
 Table 87. Egemen International Implantable Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Egemen International Implantable Contraceptive Drug Eluting Devices Product
 Table 89. Egemen International Recent Developments/Updates
 Table 90. ERENLER MEDIKAL Company Information
 Table 91. ERENLER MEDIKAL Description and Business Overview
 Table 92. ERENLER MEDIKAL Implantable Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. ERENLER MEDIKAL Implantable Contraceptive Drug Eluting Devices Product
 Table 94. ERENLER MEDIKAL Recent Developments/Updates
 Table 95. Gyneas Company Information
 Table 96. Gyneas Description and Business Overview
 Table 97. Gyneas Implantable Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Gyneas Implantable Contraceptive Drug Eluting Devices Product
 Table 99. Gyneas Recent Developments/Updates
 Table 100. Laboratoire CCD Company Information
 Table 101. Laboratoire CCD Description and Business Overview
 Table 102. Laboratoire CCD Implantable Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Laboratoire CCD Implantable Contraceptive Drug Eluting Devices Product
 Table 104. Laboratoire CCD Recent Developments/Updates
 Table 105. Medical Engineering Corporation Company Information
 Table 106. Medical Engineering Corporation Description and Business Overview
 Table 107. Medical Engineering Corporation Implantable Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Medical Engineering Corporation Implantable Contraceptive Drug Eluting Devices Product
 Table 109. Medical Engineering Corporation Recent Developments/Updates
 Table 110. Melbea Company Information
 Table 111. Melbea Description and Business Overview
 Table 112. Melbea Implantable Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Melbea Implantable Contraceptive Drug Eluting Devices Product
 Table 114. Melbea Recent Developments/Updates
 Table 115. Meril Life Sciences Company Information
 Table 116. Meril Life Sciences Description and Business Overview
 Table 117. Meril Life Sciences Implantable Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Meril Life Sciences Implantable Contraceptive Drug Eluting Devices Product
 Table 119. Meril Life Sciences Recent Developments/Updates
 Table 120. Mona Lisa Company Information
 Table 121. Mona Lisa Description and Business Overview
 Table 122. Mona Lisa Implantable Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Mona Lisa Implantable Contraceptive Drug Eluting Devices Product
 Table 124. Mona Lisa Recent Developments/Updates
 Table 125. Pregna International Company Information
 Table 126. Pregna International Description and Business Overview
 Table 127. Pregna International Implantable Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Pregna International Implantable Contraceptive Drug Eluting Devices Product
 Table 129. Pregna International Recent Developments/Updates
 Table 130. Prosan International Company Information
 Table 131. Prosan International Description and Business Overview
 Table 132. Prosan International Implantable Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. Prosan International Implantable Contraceptive Drug Eluting Devices Product
 Table 134. Prosan International Recent Developments/Updates
 Table 135. Rongbo Medical Company Information
 Table 136. Rongbo Medical Description and Business Overview
 Table 137. Rongbo Medical Implantable Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 138. Rongbo Medical Implantable Contraceptive Drug Eluting Devices Product
 Table 139. Rongbo Medical Recent Developments/Updates
 Table 140. SMB Corporation of India Company Information
 Table 141. SMB Corporation of India Description and Business Overview
 Table 142. SMB Corporation of India Implantable Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 143. SMB Corporation of India Implantable Contraceptive Drug Eluting Devices Product
 Table 144. SMB Corporation of India Recent Developments/Updates
 Table 145. Pregna Company Information
 Table 146. Pregna Description and Business Overview
 Table 147. Pregna Implantable Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 148. Pregna Implantable Contraceptive Drug Eluting Devices Product
 Table 149. Pregna Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Implantable Contraceptive Drug Eluting Devices Distributors List
 Table 153. Implantable Contraceptive Drug Eluting Devices Customers List
 Table 154. Implantable Contraceptive Drug Eluting Devices Market Trends
 Table 155. Implantable Contraceptive Drug Eluting Devices Market Drivers
 Table 156. Implantable Contraceptive Drug Eluting Devices Market Challenges
 Table 157. Implantable Contraceptive Drug Eluting Devices Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Implantable Contraceptive Drug Eluting Devices
 Figure 2. Global Implantable Contraceptive Drug Eluting Devices Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Implantable Contraceptive Drug Eluting Devices Market Share by Type: 2025 & 2032
 Figure 4. Non-biodegradable Product Picture
 Figure 5. Biodegradable Product Picture
 Figure 6. Global Implantable Contraceptive Drug Eluting Devices Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Implantable Contraceptive Drug Eluting Devices Market Share by Application: 2025 & 2032
 Figure 8. Subcutaneously
 Figure 9. Uterus
 Figure 10. Global Implantable Contraceptive Drug Eluting Devices Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 11. Global Implantable Contraceptive Drug Eluting Devices Market Size (US$ Million), 2021–2032
 Figure 12. Global Implantable Contraceptive Drug Eluting Devices Sales (K Units), 2021–2032
 Figure 13. Global Implantable Contraceptive Drug Eluting Devices Average Price (US$/Unit), 2021–2032
 Figure 14. Implantable Contraceptive Drug Eluting Devices Report Years Considered
 Figure 15. Implantable Contraceptive Drug Eluting Devices Sales Share by Manufacturers in 2025
 Figure 16. Global Implantable Contraceptive Drug Eluting Devices Revenue Share by Manufacturers in 2025
 Figure 17. Top 5 and Top 10 Global Implantable Contraceptive Drug Eluting Devices Players: Market Share by Revenue in Implantable Contraceptive Drug Eluting Devices in 2025
 Figure 18. Implantable Contraceptive Drug Eluting Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 19. Global Implantable Contraceptive Drug Eluting Devices Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 20. North America Implantable Contraceptive Drug Eluting Devices Sales Market Share by Country (2021–2032)
 Figure 21. North America Implantable Contraceptive Drug Eluting Devices Revenue Market Share by Country (2021–2032)
 Figure 22. United States Implantable Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 23. Canada Implantable Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Europe Implantable Contraceptive Drug Eluting Devices Sales Market Share by Country (2021–2032)
 Figure 25. Europe Implantable Contraceptive Drug Eluting Devices Revenue Market Share by Country (2021–2032)
 Figure 26. Germany Implantable Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. France Implantable Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. U.K. Implantable Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Italy Implantable Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Russia Implantable Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Asia Pacific Implantable Contraceptive Drug Eluting Devices Sales Market Share by Region (2021–2032)
 Figure 32. Asia Pacific Implantable Contraceptive Drug Eluting Devices Revenue Market Share by Region (2021–2032)
 Figure 33. China Implantable Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Japan Implantable Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. South Korea Implantable Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. India Implantable Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Australia Implantable Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. China Taiwan Implantable Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Southeast Asia Implantable Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Latin America Implantable Contraceptive Drug Eluting Devices Sales Market Share by Country (2021–2032)
 Figure 41. Latin America Implantable Contraceptive Drug Eluting Devices Revenue Market Share by Country (2021–2032)
 Figure 42. Mexico Implantable Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Brazil Implantable Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Argentina Implantable Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Colombia Implantable Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Middle East and Africa Implantable Contraceptive Drug Eluting Devices Sales Market Share by Country (2021–2032)
 Figure 47. Middle East and Africa Implantable Contraceptive Drug Eluting Devices Revenue Market Share by Country (2021–2032)
 Figure 48. Turkey Implantable Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Saudi Arabia Implantable Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. UAE Implantable Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Global Sales Market Share of Implantable Contraceptive Drug Eluting Devices by Type (2021–2032)
 Figure 52. Global Revenue Market Share of Implantable Contraceptive Drug Eluting Devices by Type (2021–2032)
 Figure 53. Global Implantable Contraceptive Drug Eluting Devices Price (US$/Unit) by Type (2021–2032)
 Figure 54. Global Sales Market Share of Implantable Contraceptive Drug Eluting Devices by Application (2021–2032)
 Figure 55. Global Revenue Market Share of Implantable Contraceptive Drug Eluting Devices by Application (2021–2032)
 Figure 56. Global Implantable Contraceptive Drug Eluting Devices Price (US$/Unit) by Application (2021–2032)
 Figure 57. Implantable Contraceptive Drug Eluting Devices Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc